NEO-201 has different mechanisms of action to kill target cancer cells, including ADCC, CDC and the blockade of the CEACAM5/CEACAM1 immune checkpoint inhibitory pathway [1,2,3,4]. This evidence concerns the gene CEACAM1 and cancer.